BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 468461)

  • 1. Basal cell nevus syndrome and adenocarcinoma of the colon. Response to systemic fluorouracil.
    Stone SP
    Int J Dermatol; 1979 Jun; 18(5):398-401. PubMed ID: 468461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical 5-fluorouracil and the basal-cell-nevus syndrome.
    Amon RB; Goodkin PE
    N Engl J Med; 1976 Sep; 295(12):677-8. PubMed ID: 972650
    [No Abstract]   [Full Text] [Related]  

  • 3. Basal cell nevus syndrome. Unresponsiveness of early cutaneous lesions to topical 5-fluorouracil or dinitrochlorobenzene.
    Hazen PG; Taub SJ
    Dermatologica; 1984; 168(6):287-9. PubMed ID: 6745474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute promyelocytic leukemia in a patient with colon adenocarcinoma treated with fluorouracil].
    Grau Cat J; Navarro Ferrando JT; Mate Sanz JL; Ribera Santasusana JM
    Med Clin (Barc); 2007 Mar; 128(12):478-9. PubMed ID: 17408544
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple basal cell naevus syndrome--successful treatment of basal cell tumours with 5-fluorouracil.
    Moynahan EJ
    Proc R Soc Med; 1973 Jul; 66(7):627-8. PubMed ID: 4741390
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumors of the skin. VI. Study on effects of local administration of 5-fluorouracil in basal cell carcinoma.
    Klein E; Stoll HL; Milgrom H; Traenkle HL; Graham S; Helm F
    J Invest Dermatol; 1966 Aug; 47(1):22-6. PubMed ID: 25622345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of basal cell epithelioma of the skin with topical 5-fluorouracil].
    Lukowska I
    Przegl Dermatol; 1974; 61(2):201-4. PubMed ID: 4832864
    [No Abstract]   [Full Text] [Related]  

  • 8. 5-fluorouracil in management of Gorlin's syndrome.
    Labandter HP; Ryan RF
    N Engl J Med; 1978 Apr; 298(16):913. PubMed ID: 634337
    [No Abstract]   [Full Text] [Related]  

  • 9. Basal cell carcinoma responding to systemic 5-fluorouracil.
    Snipes CJ; Sniezek PJ; Walling HW
    J Am Acad Dermatol; 2006 Jun; 54(6):1104-6. PubMed ID: 16713484
    [No Abstract]   [Full Text] [Related]  

  • 10. Comprehensive treatment of basal cell carcinoma in nevoid basal cell carcinoma syndrome with 5-fluorouracil and salicylic acid.
    Yu Y; Zhang G; Fu S
    Dermatol Ther; 2022 Dec; 35(12):e15972. PubMed ID: 36346027
    [No Abstract]   [Full Text] [Related]  

  • 11. 5-fluorouracil in Gorlin's syndrome.
    Labandter HP; Ryan RF
    J La State Med Soc; 1978 Apr; 130(4):79-82. PubMed ID: 650053
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term management of basal cell nevus syndrome with topical tretinoin and 5-fluorouracil.
    Strange PR; Lang PG
    J Am Acad Dermatol; 1992 Nov; 27(5 Pt 2):842-5. PubMed ID: 1469141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal-cell-nevus syndrome and gastrointestinal polyposis.
    Schwartz RA
    N Engl J Med; 1978 Jul; 299(1):49. PubMed ID: 661854
    [No Abstract]   [Full Text] [Related]  

  • 14. Squamous-cell carcinoma arising in a basal-cell epithelioma treated with 5-fluorouracil.
    Kurtis B; Rosen T
    J Dermatol Surg Oncol; 1979 May; 5(5):394-6. PubMed ID: 458006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The topical application of 5-fluorouracil in the treatment of skin lesions.
    Kastl WH; Knoepp LF; Soosaar A
    J La State Med Soc; 1969 Jul; 121(7):216-8. PubMed ID: 5797536
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical chemotherapy of basal and squamous skin cancers with 5-fluorouracil cream.
    Litwin MS; Krementz ET
    Panminerva Med; 1974 Mar; 16(3):84-5. PubMed ID: 4449647
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical 5-fluorouracil: variability of effective dosage and duration of reaction.
    Sykes MP; Salem P; Joffe B
    J Am Geriatr Soc; 1971 Dec; 19(12):977-82. PubMed ID: 5153692
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of cutaneous tumors with fluorouracil ointment].
    Avrach W; Ziprkowski L
    Harefuah; 1971 Nov; 81(9):431-2. PubMed ID: 5142373
    [No Abstract]   [Full Text] [Related]  

  • 19. Tendency of fluorouracil to conceal deep foci of invasive basal cell carcinoma.
    Mohs FE; Jones DL; Bloom RF
    Arch Dermatol; 1978 Jul; 114(7):1021-2. PubMed ID: 686718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU).
    Kurtis B; Rosen T
    J Dermatol Surg Oncol; 1980 Feb; 6(2):122-7. PubMed ID: 7354186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.